{"hands_on_practices": [{"introduction": "Understanding the rate at which a biodegradable implant loses mass is crucial for designing devices with a predictable functional lifetime. This exercise introduces a first-order kinetic model, a common and powerful tool to describe the hydrolysis of polymers like Poly(glycolic acid) (PGA). By working through this problem, you will practice applying this mathematical framework to calculate the remaining mass of a tissue engineering scaffold, a fundamental skill in quantitative materials science [@problem_id:1286018].", "problem": "A materials scientist is investigating the degradation behavior of a new biomedical scaffold designed for tissue engineering. The scaffold is fabricated from porous Poly(glycolic acid) (PGA), a biodegradable polymer that breaks down in the body via hydrolysis of its ester linkages. To simulate physiological conditions, a scaffold with an initial dry mass of $m_0 = 500.0$ mg is submerged in a Phosphate-Buffered Saline (PBS) solution maintained at a constant temperature of $37.0^\\circ\\text{C}$. Under these conditions, the mass loss due to hydrolysis can be accurately modeled as a first-order kinetic process with a rate constant of $k = 0.0250 \\text{ day}^{-1}$.\n\nCalculate the expected dry mass of the scaffold after it has been submerged in the PBS solution for a period of $t = 30.0$ days. Express your final answer in milligrams (mg) and round it to three significant figures.", "solution": "The problem asks for the remaining mass of a Poly(glycolic acid) (PGA) scaffold after a certain period of degradation. The degradation process is described as following first-order kinetics.\n\nThe governing equation for a first-order kinetic process is:\n$$A(t) = A_0 \\exp(-kt)$$\nwhere $A(t)$ is the amount of substance remaining at time $t$, $A_0$ is the initial amount of the substance, $k$ is the first-order rate constant, and $t$ is the time elapsed.\n\nIn this problem, the \"amount of substance\" is the mass of the PGA scaffold. Therefore, we can write the equation in terms of mass, $m$:\n$$m(t) = m_0 \\exp(-kt)$$\n\nWe are given the following values from the problem statement:\n- The initial dry mass of the scaffold, $m_0 = 500.0$ mg.\n- The first-order rate constant for hydrolysis, $k = 0.0250 \\text{ day}^{-1}$.\n- The time period of submersion, $t = 30.0$ days.\n\nOur goal is to calculate the mass remaining at $t = 30.0$ days, which is $m(30.0)$.\n\nFirst, we substitute the given values into the equation:\n$$m(30.0) = (500.0 \\text{ mg}) \\times \\exp\\left(-\\left(0.0250 \\text{ day}^{-1}\\right) \\times \\left(30.0 \\text{ days}\\right)\\right)$$\n\nNext, we calculate the value of the exponent, $kt$.\n$$kt = (0.0250 \\text{ day}^{-1}) \\times (30.0 \\text{ days}) = 0.750$$\nThe units of days and day$^{-1}$ cancel out, leaving a dimensionless exponent as expected.\n\nNow, substitute this value back into the mass equation:\n$$m(30.0) = 500.0 \\text{ mg} \\times \\exp(-0.750)$$\n\nWe need to evaluate the exponential term, $\\exp(-0.750)$:\n$$\\exp(-0.750) \\approx 0.47236655$$\n\nFinally, we calculate the mass $m(30.0)$:\n$$m(30.0) \\approx 500.0 \\text{ mg} \\times 0.47236655$$\n$$m(30.0) \\approx 236.183275 \\text{ mg}$$\n\nThe problem requires the final answer to be rounded to three significant figures. The input values $k$ and $t$ have three significant figures, which is the least number of significant figures among the inputs used in the multiplication within the exponent.\nRounding the calculated mass, $236.183275$ mg, to three significant figures gives:\n$$m(30.0) = 236 \\text{ mg}$$", "answer": "$$\\boxed{236}$$", "id": "1286018"}, {"introduction": "The process of degradation in semi-crystalline polymers involves more than just simple mass loss; it can also trigger significant changes in the material's microstructure and mechanical properties. This practice explores the fascinating phenomenon where initial degradation in the amorphous regions of Poly(L-lactic acid) (PLLA) can lead to an increase in overall crystallinity and stiffness. By modeling the Young's modulus, you will gain insight into how a biodegradable stent's mechanical performance can evolve in vivo, a critical consideration for ensuring implant safety and efficacy [@problem_id:1285985].", "problem": "A biomedical engineer is studying a new type of biodegradable arterial stent made from Poly(L-lactic acid) (PLLA). The mechanical properties of PLLA are highly dependent on its degree of crystallinity. The overall Young's modulus, $E$, of this semi-crystalline polymer can be accurately modeled as a simple volume-fraction-weighted average of the modulus of the purely crystalline phase, $E_{cryst}$, and the purely amorphous phase, $E_{amorph}$.\n\nA newly manufactured stent has an initial volume fraction of crystallinity of $0.40$. The material properties are given as $E_{cryst} = 5.0$ GPa and $E_{amorph} = 1.8$ GPa.\n\nAfter the stent is implanted, it is exposed to the body's aqueous environment. The ester bonds in the PLLA chains begin to hydrolyze, a process that preferentially targets the less-ordered amorphous regions. This chain scission allows the newly mobile, shorter polymer segments to rearrange and crystallize. After an initial period of *in vivo* degradation, it is found that an amount of material equivalent to $25\\%$ of the *initial* amorphous volume has been converted into new crystalline regions.\n\nAssuming the total volume of the polymer remains constant during this initial phase, calculate the new Young's modulus of the stent material. Express your answer in GPa, rounded to three significant figures.", "solution": "The rule of mixtures for a two-phase semi-crystalline polymer with constant total volume gives the Young's modulus as a volume-fraction-weighted average:\n$$\nE = f_{c} E_{cryst} + f_{a} E_{amorph},\n$$\nwhere $f_{c}$ and $f_{a}$ are the crystalline and amorphous volume fractions, with $f_{c} + f_{a} = 1$.\n\nInitially, the crystalline fraction is $f_{c,0} = 0.40$, so the amorphous fraction is\n$$\nf_{a,0} = 1 - f_{c,0} = 1 - 0.40 = 0.60.\n$$\nAn amount equal to $0.25$ of the initial amorphous volume converts to crystalline, so the change in fraction is\n$$\n\\Delta f = 0.25 \\times f_{a,0} = 0.25 \\times 0.60 = 0.15.\n$$\nWith constant total volume, the new fractions are\n$$\nf_{c,1} = f_{c,0} + \\Delta f = 0.40 + 0.15 = 0.55,\\quad f_{a,1} = f_{a,0} - \\Delta f = 0.60 - 0.15 = 0.45,\n$$\nand $f_{c,1} + f_{a,1} = 1$ as required.\n\nThe new modulus is therefore\n$$\nE_{1} = f_{c,1} E_{cryst} + f_{a,1} E_{amorph} = 0.55 \\times 5.0 + 0.45 \\times 1.8 \\text{ GPa}.\n$$\nCompute each term:\n$$\n0.55 \\times 5.0 = 2.75 \\text{ GPa},\\quad 0.45 \\times 1.8 = 0.81 \\text{ GPa},\n$$\nso\n$$\nE_{1} = 2.75 + 0.81 = 3.56 \\text{ GPa}.\n$$\nRounded to three significant figures, the value is $3.56$ in GPa.", "answer": "$$\\boxed{3.56}$$", "id": "1285985"}, {"introduction": "A primary application of biodegradable polymers is in creating systems for controlled drug delivery, where the polymer's degradation dictates the rate of drug release. This exercise asks you to connect the underlying degradation mechanism—in this case, bulk erosion—to the resulting drug release profile over time. Developing the ability to qualitatively predict these profiles is essential for designing effective therapeutic systems that release drugs in a desired pattern, from delayed release to sustained delivery [@problem_id:1286023].", "problem": "In the field of controlled drug delivery, biodegradable polymers are often used to create micro-scale carriers that release a therapeutic agent over time. Consider a system where a water-soluble drug is uniformly dispersed throughout a solid, spherical microsphere made of poly(caprolactone) (PCL), a common biodegradable polyester.\n\nThe drug release from this specific PCL formulation is known to be governed purely by **bulk erosion**. In this mechanism, water penetrates the entire polymer matrix relatively quickly, and the hydrolytic degradation of the polymer's ester bonds occurs throughout the volume of the microsphere. The rate of water ingress is much faster than the rate of polymer chain cleavage. Consequently, the polymer loses its molecular weight and mechanical integrity uniformly throughout its structure over time. The drug is released as the polymer matrix physically disintegrates.\n\nWhich of the following statements provides the most accurate qualitative description of the cumulative percentage of drug released from the microsphere as a function of time?\n\nA. The release profile is sigmoidal (S-shaped). There is an initial lag phase with very little drug release, followed by a period of rapid, accelerated release, which finally slows down as the drug supply is exhausted and the curve flattens to a plateau.\n\nB. The release profile is linear (zero-order). The drug is released at a nearly constant rate from the beginning until all the drug has been depleted, at which point the release abruptly stops.\n\nC. The release profile shows a large initial burst. A significant fraction of the drug is released very quickly, after which the release rate continuously decreases, approaching a plateau asymptotically.\n\nD. The drug release is instantaneous. The entire drug load is released immediately upon placing the microsphere in an aqueous environment.\n\nE. The release profile is biphasic, characterized by a rapid initial burst followed by a prolonged phase of linear, constant-rate release.", "solution": "We identify the governing physical mechanism as bulk erosion: water penetration into the polymer matrix is much faster than polymer chain cleavage. Let the characteristic time for water ingress be $t_{w}$ and the characteristic time for ester hydrolysis be $t_{h}$. Bulk erosion implies $t_{w} \\ll t_{h}$ so the entire volume is hydrated rapidly while molecular weight decreases uniformly throughout the sphere.\n\nFor a drug uniformly dispersed and water-soluble, with negligible diffusional release before matrix disintegration, the cumulative fractional release $M_{t}/M_{\\infty}$ versus time $t$ is governed by the structural integrity of the matrix. The qualitative stages are:\n1) Early times: The polymer network remains intact even though molecular weight decreases, so there are no continuous pathways for drug escape. Thus, $M_{t}/M_{\\infty}$ increases very slowly, corresponding to a lag phase.\n2) Intermediate times: As the number-average molecular weight crosses a critical threshold (gel point), the matrix develops percolating porosity and loses mechanical integrity. This triggers rapid mass loss of the polymer and accelerated drug liberation throughout the volume, so the slope of $M_{t}/M_{\\infty}$ versus $t$ increases substantially.\n3) Late times: As the internal drug is depleted and the remaining fragments contain little drug, the release rate diminishes and $M_{t}/M_{\\infty}$ approaches an asymptote.\n\nThis sequence corresponds to a sigmoidal (S-shaped) cumulative release curve: an initial lag with minimal release, followed by accelerated release, then a deceleration as the drug load is exhausted.\n\nComparison with options:\n- A matches the sigmoidal profile inherent to bulk erosion with uniform drug distribution and negligible early diffusion.\n- B (zero-order) is characteristic of surface erosion with approximately constant surface area, not bulk erosion.\n- C (large initial burst then monotonic slowdown) reflects significant initial diffusion from surface-localized drug, which contradicts the assumption of purely bulk erosion with uniform dispersion.\n- D (instantaneous release) is incompatible with polymer erosion kinetics.\n- E (burst followed by linear) again implies initial surface-associated diffusion and then surface erosion-like behavior, not purely bulk erosion.\n\nTherefore, the most accurate qualitative description is sigmoidal, as in option A.", "answer": "$$\\boxed{A}$$", "id": "1286023"}]}